https://pf-00562271inhibitor.c....om/a-case-of-reexpan
We performed an observational research that included 223 consecutive patients post optical coherence tomography-guided implantation of either Absorb bioresorbable scaffolds (162 customers) or everolimus drug-eluting stents (61 customers). We learned the influence of optical coherence tomography on intraoperative decision-making during implantation of bioresorbable scaffolds versus drug-eluting stents by analyzing the full total rate of optical coherence tomography-dependent improvements in
Like
Comment
Share
